Çerman Eren, Akkaya Turhan Semra, Eraslan Muhsin, Kahraman Koytak Pınar, Kilinç Özden, Tanrıdağ Tülin
Marmara University School of Medicine, Department of Ophthalmology, Istanbul, Turkey.
Marmara University School of Medicine, Department of Ophthalmology, Istanbul, Turkey.
Can J Ophthalmol. 2017 Feb;52(1):20-25. doi: 10.1016/j.jcjo.2016.07.025. Epub 2016 Nov 25.
To investigate the accommodation function in topiramate users.
Case-control clinical study.
The participants included 16 controls and 22 patients using 100 mg/kg topiramate who were diagnosed with migraine according to the International Classification of Headache Disorders, second edition criteria.
One-minute dynamic measurements of refraction with accommodation stimuli of 0 D, 2 D, 2.5 D, 3 D, 4 D, and 5 D were obtained using the open field refractometer WAM-5500 in.
In most of the accommodation stimuli ranges (0 D, 2.5 D, 3 D, and 5 D), topiramate users had a significantly higher accommodative lag compared with controls (p = 0.028, p = 0.014, p = 0.011, and p = 0.011, respectively). The most important causes of accommodative lag were found to be accommodation stimulus and inclusion in the topiramate group (p < 0.001, R = 0.32, 95% CI 0.22-0.37 and 0.42-0.91, respectively). Multivariate linear regression analysis revealed that the 2 most important predictors of accommodative lag were accommodation stimulus and age (p < 0.001, r = 0.51, 95% CI 0.31-0.32 and 0.67-0.69, respectively) CONCLUSIONS: Even after adjustment for age, accommodative lag is greater across several accommodative stimulus levels in patients using topiramate, which may be related to visual symptoms in topiramate users.
研究托吡酯使用者的调节功能。
病例对照临床研究。
参与者包括16名对照者和22名使用100mg/kg托吡酯的患者,这些患者根据《国际头痛疾病分类》第二版标准被诊断为偏头痛。
使用开放式视野验光仪WAM-5500对0D、2D、2.5D、3D、4D和5D的调节刺激进行一分钟动态屈光测量。
在大多数调节刺激范围内(0D、2.5D、3D和5D),与对照者相比,托吡酯使用者的调节滞后明显更高(p分别为0.028、0.014、0.011和0.011)。发现调节滞后的最重要原因是调节刺激和纳入托吡酯组(p<0.001,R分别为0.32,95%CI为0.22 - 0.37和0.42 - 0.91)。多变量线性回归分析显示,调节滞后的两个最重要预测因素是调节刺激和年龄(p<0.001,r分别为0.51,95%CI为0.31 - 0.32和0.67 - 0.69)。结论:即使在对年龄进行调整后,使用托吡酯的患者在几个调节刺激水平上的调节滞后仍然更大,这可能与托吡酯使用者的视觉症状有关。